Literature DB >> 18177785

Polytomous logistic regression analysis could be applied more often in diagnostic research.

C J Biesheuvel1, Y Vergouwe, E W Steyerberg, D E Grobbee, K G M Moons.   

Abstract

OBJECTIVE: Physicians commonly consider the presence of all differential diagnoses simultaneously. Polytomous logistic regression modeling allows for simultaneous estimation of the probability of multiple diagnoses. We discuss and (empirically) illustrate the value of this method for diagnostic research. STUDY DESIGN AND
SETTING: We used data from a study on the diagnosis of residual retroperitoneal mass histology in patients presenting with nonseminomatous testicular germ cell tumor. The differential diagnoses include benign tissue, mature teratoma, and viable cancer. Probabilities of each diagnosis were estimated with a polytomous logistic regression model and compared with the probabilities estimated from two consecutive dichotomous logistic regression models.
RESULTS: We provide interpretations of the odds ratios derived from the polytomous regression model and present a simple score chart to facilitate calculation of predicted probabilities from the polytomous model. For both modeling methods, we show the calibration plots and receiver operating characteristics curve (ROC) areas comparing each diagnostic outcome category with the other two. The ROC areas for benign tissue, mature teratoma, and viable cancer were similar for both modeling methods, 0.83 (95% confidence interval [CI]=0.80-0.85) vs. 0.83 (95% CI=0.80-0.85), 0.78 (95% CI=0.75-0.81) vs. 0.78 (95% CI=0.75-0.81), and 0.66 (95% CI=0.61-0.71) vs. 0.64 (95% CI=0.59-0.69), for polytomous and dichotomous regression models, respectively.
CONCLUSION: Polytomous logistic regression is a useful technique to simultaneously model predicted probabilities of multiple diagnostic outcome categories. The performance of a polytomous prediction model can be assessed similarly to a dichotomous logistic regression model, and predictions by a polytomous model can be made with a user-friendly method. Because the simultaneous consideration of the presence of multiple (differential) conditions serves clinical practice better than consideration of the presence of only one target condition, polytomous logistic regression could be applied more often in diagnostic research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18177785     DOI: 10.1016/j.jclinepi.2007.03.002

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  36 in total

1.  Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes.

Authors:  Terry Hyslop; David S Weinberg; Stephanie Schulz; Alan Barkun; Scott A Waldman
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

2.  Risk Prediction for Early CKD in Type 2 Diabetes.

Authors:  Daniela Dunkler; Peggy Gao; Shun Fu Lee; Georg Heinze; Catherine M Clase; Sheldon Tobe; Koon K Teo; Hertzel Gerstein; Johannes F E Mann; Rainer Oberbauer
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-14       Impact factor: 8.237

3.  Assessing the discriminative ability of risk models for more than two outcome categories.

Authors:  Ben Van Calster; Yvonne Vergouwe; Caspar W N Looman; Vanya Van Belle; Dirk Timmerman; Ewout W Steyerberg
Journal:  Eur J Epidemiol       Date:  2012-10-07       Impact factor: 8.082

4.  Associations between measures of central adiposity and periodontitis among older adults.

Authors:  Francisco J Muñoz-Torres; Monik C Jiménez; Sona Rivas-Tumanyan; Kaumudi J Joshipura
Journal:  Community Dent Oral Epidemiol       Date:  2013-09-07       Impact factor: 3.383

5.  Work Ability Index as tool to identify workers at risk of premature work exit.

Authors:  Corné A M Roelen; Martijn W Heymans; Jos W R Twisk; Jac J L van der Klink; Johan W Groothoff; Willem van Rhenen
Journal:  J Occup Rehabil       Date:  2014-12

6.  Prediction of recovery, dependence or death in elders who become disabled during hospitalization.

Authors:  Deborah E Barnes; Kala M Mehta; W John Boscardin; Richard H Fortinsky; Robert M Palmer; Katharine A Kirby; C Seth Landefeld
Journal:  J Gen Intern Med       Date:  2012-09-30       Impact factor: 5.128

7.  Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.

Authors:  Claudia A Salinas; Erika M Kwon; Liesel M FitzGerald; Ziding Feng; Peter S Nelson; Elaine A Ostrander; Ulrike Peters; Janet L Stanford
Journal:  Am J Epidemiol       Date:  2010-08-05       Impact factor: 4.897

8.  Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos.

Authors:  Mayer B Davidson; Petra Duran; Martin L Lee
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

9.  Polytomous diagnosis of ovarian tumors as benign, borderline, primary invasive or metastatic: development and validation of standard and kernel-based risk prediction models.

Authors:  Ben Van Calster; Lil Valentin; Caroline Van Holsbeke; Antonia C Testa; Tom Bourne; Sabine Van Huffel; Dirk Timmerman
Journal:  BMC Med Res Methodol       Date:  2010-10-20       Impact factor: 4.615

10.  Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk.

Authors:  Yong Cui; Sandra L Deming-Halverson; Alicia Beeghly-Fadiel; Loren Lipworth; Martha J Shrubsole; Alecia M Fair; Xiao-Ou Shu; Wei Zheng
Journal:  Clin Cancer Res       Date:  2014-01-14       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.